Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRH reversal of opioid-induced respiratory depression and analgesia in healthy volunteers
NL-OMON21474Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Trial of thyrotropin-releasing hormone in opioid-induced respiratory depression (OIRD) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Respiratory measurements. Started Apr 2018; status: recruiting.
02
Drugs
thyrotropin-releasing hormone
03
Conditions
opioid-induced respiratory depression (OIRD)
Beyond the preview
Go deeper on NL-OMON21474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21474.